Key result
Self-reported adherence to dual antiplatelet therapy was moderate (mean SEAMS score 30.8), and was significantly associated with health insurance and income (p < 0.05).
Why the study?
The study was conducted to evaluate patients' self-reported adherence to dual antiplatelet therapy and identify factors linked to premature discontinuation.
What is the level of adherence to dual antiplatelet therapy and what factors are associated with premature discontinuation in patients with acute coronary syndrome?
Cross-Sectional (n=192)
No
What is the level of adherence to dual antiplatelet therapy and what factors are associated with premature discontinuation in patients with acute coronary syndrome?
Patients with ACS in Saudi Arabia demonstrated moderate adherence to DAPT, with adherence significantly influenced by health insurance and income.
Moderate DAPT adherence linked to insurance and income in Saudi ACS; leaves open targeted interventions and prospective studies.
OBJECTIVES: The aim of this study was to evaluate patients' self-reported adherence to dual antiplatelet therapy (DAPT) and determine the factors associated with premature discontinuation of DAPT. METHODS: The cross-sectional interview-based study was conducted among adult outpatients who visited the outpatient department of King Khalid University Hospital, Cardiac Center in Riyadh, Saudi Arabia, over a period of 3 months from May to July of 2016. Medication adherence was assessed using the Self-efficacy for Appropriate Medication Use Scale (SEAMS), which is composed of 13 items with a 3-point Likert scale. RESULTS: A total of 192 patients participated in the study. The majority of the participants were male (82.1%), and the mean age was 55.66 ± 10.80 years. More than 84% (84.4%) of the patients reported that they were "confident" in taking several medications each day. The minimum and maximum SEAMS scores were 22 and 39, respectively, with the mean score being 30.8 ± 3.5. Almost all patients had moderate scores and adherence; only one patient got a score of 39. Among sociodemographic characteristics, only health insurance and income were significantly associated with the medication adherence score (p < 0.05). CONCLUSIONS: Study results concluded that patients had a moderate level of adherence towards DAPT in Saudi Arabia, however Patient education on DAPT is essential to improve adherence to medication treatment. More effective intentions and education methods should be developed to improve long-term DAPT adherence.
No takes yet. Share an insight, caveat, or question.
Alrabiah et al. (2020) conducted a cross-sectional in Acute coronary syndrome (n=192). Dual antiplatelet therapy (DAPT) was evaluated on Medication adherence assessed using the Self-efficacy for Appropriate Medication Use Scale (SEAMS). Self-reported adherence to dual antiplatelet therapy was moderate (mean SEAMS score 30.8), and was significantly associated with health insurance and income (p < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: